2023 Semi-annual Report
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
2023 Semi-annual Report
Filed with SSE ·
2023 Semi-annual Report
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
6ix hasn’t read this filing yet.
Mayinglong Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Mayinglong Pharmaceutical
- Announcement on Implementation of Dividend Distribution of 2022
- Announcement on Adjusting Member of Special Committee
- Notice on Convening 2022 Annual General Meeting
- Announcement on Convening Performance Meeting for 2022 and 1st Quarter of 2023
- Announcement on Progress in Participation in Investing in Private Fund
Later from Mayinglong Pharmaceutical
- Announcement on Convening 2023 Semi-annual Performance Meeting
- 3rd Quarter Report of 2023
- Announcement on Release of Pledge and Re-Pledge of Some Shares by Controlling Shareholder
- Announcement on Resolutions of 11th Session of 11th Board of Directors
- Announcement on Resolutions of 12th Session of 11th Board of Directors
Follow Mayinglong Pharmaceutical into a list and get an email when it puts out news.
Follow Mayinglong Pharmaceutical